Global Personalized Medicines Market Research Report 2023

Publication ID:

PB502230864

Publication Date:

February 1, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Highlights
The global Personalized Medicines market was valued at US$ 291120 million in 2022 and is anticipated to reach US$ 540120 million by 2029, witnessing a CAGR of 10.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines.
The Personalized Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Personalized Medicines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Segment by Type
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicines companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines Market Perspective (2018-2029)
2.2 Personalized Medicines Growth Trends by Region
2.2.1 Global Personalized Medicines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Personalized Medicines Historic Market Size by Region (2018-2023)
2.2.3 Personalized Medicines Forecasted Market Size by Region (2024-2029)
2.3 Personalized Medicines Market Dynamics
2.3.1 Personalized Medicines Industry Trends
2.3.2 Personalized Medicines Market Drivers
2.3.3 Personalized Medicines Market Challenges
2.3.4 Personalized Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines Players by Revenue
3.1.1 Global Top Personalized Medicines Players by Revenue (2018-2023)
3.1.2 Global Personalized Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines Revenue
3.4 Global Personalized Medicines Market Concentration Ratio
3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2022
3.5 Personalized Medicines Key Players Head office and Area Served
3.6 Key Players Personalized Medicines Product Solution and Service
3.7 Date of Enter into Personalized Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines Breakdown Data by Type
4.1 Global Personalized Medicines Historic Market Size by Type (2018-2023)
4.2 Global Personalized Medicines Forecasted Market Size by Type (2024-2029)
5 Personalized Medicines Breakdown Data by Application
5.1 Global Personalized Medicines Historic Market Size by Application (2018-2023)
5.2 Global Personalized Medicines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Personalized Medicines Market Size (2018-2029)
6.2 North America Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Personalized Medicines Market Size by Country (2018-2023)
6.4 North America Personalized Medicines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines Market Size (2018-2029)
7.2 Europe Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Personalized Medicines Market Size by Country (2018-2023)
7.4 Europe Personalized Medicines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines Market Size (2018-2029)
8.2 Asia-Pacific Personalized Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Personalized Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Personalized Medicines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines Market Size (2018-2029)
9.2 Latin America Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Personalized Medicines Market Size by Country (2018-2023)
9.4 Latin America Personalized Medicines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines Market Size (2018-2029)
10.2 Middle East & Africa Personalized Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Personalized Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Personalized Medicines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3G Biotech
11.1.1 3G Biotech Company Detail
11.1.2 3G Biotech Business Overview
11.1.3 3G Biotech Personalized Medicines Introduction
11.1.4 3G Biotech Revenue in Personalized Medicines Business (2018-2023)
11.1.5 3G Biotech Recent Development
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Detail
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Personalized Medicines Introduction
11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2018-2023)
11.2.5 Quest Diagnostics Recent Development
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Company Detail
11.3.2 Laboratory Corporation of America Business Overview
11.3.3 Laboratory Corporation of America Personalized Medicines Introduction
11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2018-2023)
11.3.5 Laboratory Corporation of America Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Personalized Medicines Introduction
11.4.4 Abbott Revenue in Personalized Medicines Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Agendia NV
11.5.1 Agendia NV Company Detail
11.5.2 Agendia NV Business Overview
11.5.3 Agendia NV Personalized Medicines Introduction
11.5.4 Agendia NV Revenue in Personalized Medicines Business (2018-2023)
11.5.5 Agendia NV Recent Development
11.6 Asuragen Inc
11.6.1 Asuragen Inc Company Detail
11.6.2 Asuragen Inc Business Overview
11.6.3 Asuragen Inc Personalized Medicines Introduction
11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2018-2023)
11.6.5 Asuragen Inc Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Personalized Medicines Introduction
11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2018-2023)
11.7.5 Becton Dickinson Recent Development
11.8 CardioDx Inc.
11.8.1 CardioDx Inc. Company Detail
11.8.2 CardioDx Inc. Business Overview
11.8.3 CardioDx Inc. Personalized Medicines Introduction
11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2018-2023)
11.8.5 CardioDx Inc. Recent Development
11.9 Foundation Medicine
11.9.1 Foundation Medicine Company Detail
11.9.2 Foundation Medicine Business Overview
11.9.3 Foundation Medicine Personalized Medicines Introduction
11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2018-2023)
11.9.5 Foundation Medicine Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Personalized Medicines Introduction
11.10.4 Qiagen Revenue in Personalized Medicines Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Detail
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Personalized Medicines Introduction
11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2018-2023)
11.11.5 Siemens Healthcare Recent Development
11.12 Amgen
11.12.1 Amgen Company Detail
11.12.2 Amgen Business Overview
11.12.3 Amgen Personalized Medicines Introduction
11.12.4 Amgen Revenue in Personalized Medicines Business (2018-2023)
11.12.5 Amgen Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Detail
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2018-2023)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 GE Healthcare
11.14.1 GE Healthcare Company Detail
11.14.2 GE Healthcare Business Overview
11.14.3 GE Healthcare Personalized Medicines Introduction
11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2018-2023)
11.14.5 GE Healthcare Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Detail
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Personalized Medicines Introduction
11.15.4 Pfizer Revenue in Personalized Medicines Business (2018-2023)
11.15.5 Pfizer Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Detail
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Personalized Medicines Introduction
11.16.4 Sanofi Revenue in Personalized Medicines Business (2018-2023)
11.16.5 Sanofi Recent Development
11.17 23andMe
11.17.1 23andMe Company Detail
11.17.2 23andMe Business Overview
11.17.3 23andMe Personalized Medicines Introduction
11.17.4 23andMe Revenue in Personalized Medicines Business (2018-2023)
11.17.5 23andMe Recent Development
11.18 Illumina
11.18.1 Illumina Company Detail
11.18.2 Illumina Business Overview
11.18.3 Illumina Personalized Medicines Introduction
11.18.4 Illumina Revenue in Personalized Medicines Business (2018-2023)
11.18.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂